Search clinical trials for: fluticasone propionate/salmeterol

Total 1299 results

University of Dundee
AstraZeneca; NHS Tayside

Completed

Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial (MUSIC)

Chronic Obstructive Pulmonary Disease

United Kingdom
Tampere University Hospital

Active, not recruiting

The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype

Chronic Rhinosinusitis (Diagnosis)

Finland
Optinose US Inc.

Completed

Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety

Bilateral Nasal Polyposis

United States, Canada
SkyePharma AG

Completed

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

Asthma

United States, Canada
St. Paul's Sinus Centre

Withdrawn

Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

Allergic Rhinitis
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Individualized Therapy For Asthma in Toddlers (INFANT)

Asthma | Wheezing

United States
University Hospitals, Leicester
Genentech, Inc.

Active, not recruiting

A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers

Healthy

United Kingdom
Marc Rothenberg, MD

Completed

A Study of Flovent in Patients With Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Optinose US Inc.

Completed

Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device

Bilateral Nasal Polyposis

United States
GlaxoSmithKline

Completed

Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber

Rhinitis, Allergic, Perennial

Germany
Marc Rothenberg

Completed

A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders

Eosinophilic Esophagitis

United States
GlaxoSmithKline

Completed

A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

Allergic Rhinitis | Rhinitis, Allergic, Perennial

Austria
Amsterdam UMC, location VUmc
GlaxoSmithKline; The Netherlands Cancer Institute

Completed

Randomized Trial of Fluticasone in Bronchial Premalignancy

Bronchogenic Carcinoma

Netherlands
Optinose US Inc.

Completed

12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device

Nasal Polyps

United States
GlaxoSmithKline

Completed

Assessment of Fluticasone Propionate on Ocular Allergy Symptoms

Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
GlaxoSmithKline
Adelphi Real World

Completed

A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

Rhinitis, Allergic, Perennial
Nicox Ophthalmics, Inc.

Completed

Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis

Blepharitis

United States
NYU Langone Health

Completed

Biomarkers of Irritant-Induced and Allergic Asthma

Asthma

United States
Hvidovre University Hospital

Recruiting

Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma

Asthma

Denmark
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial (SAPS)

Asthma

United States
GlaxoSmithKline

Completed

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Asthma

United States, Argentina, Germany, Japan, Chile, Peru, Philippines, Poland, Mexico, Slovakia, Ukraine, South Africa, Puerto Rico, Georgia
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Asthma

United States
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Asthma

United States
Pfizer

Completed

A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Asthma

United Kingdom
University of Medicine and Pharmacy at Ho Chi Minh...

Recruiting

FLuticasone in cOvid Treatment (FLOT) (FLOT)

Covid19

Vietnam
Boehringer Ingelheim

Terminated

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

Asthma

United States
Regeneron Pharmaceuticals
Sanofi

Completed

Study of REGN3500 and Dupilumab in Patients With Asthma

Asthma, Allergic

United Kingdom, United States
Ramathibodi Hospital

Completed

Nebulized Corticosteroid for Post Extubation Stridor in Children

Stridor

Thailand
University of Florida
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Dose-Response of Salmeterol in Children

Asthma

United States
AstraZeneca

Completed

Symbicort Onset of Action 1

Asthma
Bristol-Myers Squibb

Completed

Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care

Chronic Hepatitis C

France, United States, Puerto Rico
Meda Pharmaceuticals

Completed

A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
University Hospital, Ghent
MEDA Pharma GmbH & Co. KG; University of Wuerzburg

Withdrawn

Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (BIODYMF)

Bioavailability Study

Belgium
University of Dundee

Completed

Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma

Asthma

United Kingdom
Research Consult GmbH

Completed

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
Xijing Hospital

Unknown

A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma

Asthma in Children

China
University Health Network, Toronto

Completed

Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma

Ocular Hypertension | Glaucoma, Open-Angle
Fougera Pharmaceuticals Inc.

Completed

Cutivate Lotion HPA Axis Pediatric Study

Atopic Dermatitis

United States
GlaxoSmithKline

Completed

A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients

Asthma | Mild Asthma
Joseph Dohar, MD

Recruiting

The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children

Vocal Fold Nodules

United States
GlaxoSmithKline

Completed

FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects

Asthma

United States
Meda Pharmaceuticals

Completed

3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis

Allergic Rhinitis

United States
Palau Pharma S.A.

Completed

Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

Seasonal Allergic Rhinitis

Germany
Research in Real-Life Ltd
Chiesi Farmaceutici S.p.A.

Completed

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management (Fos/Ser_switch)

Asthma

United Kingdom
GlaxoSmithKline

Completed

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Asthma

United States, Canada
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

Asthma

Germany, Poland, United States, France, Netherlands, South Africa, United Kingdom, Norway
Novartis

Completed

Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

Asthma

Germany, India
Makerere University
University of Copenhagen

Completed

Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial (ICS)

Bacterial Pneumonia | Acute Asthma | Viral Pneumonia

Uganda
ORA, Inc.

Completed

An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo

Allergic Rhinitis | Allergic Conjunctivitis

United States

3

Subscribe